Relative Bioavailability of a Single Oral Dose of BI 1015550 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 31 Jul 2018
At a glance
- Drugs BI 1015550 (Primary) ; Itraconazole
- Indications Idiopathic pulmonary fibrosis; Unspecified
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 23 Jul 2018 Status changed from active, no longer recruiting to completed.
- 03 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 08 May 2018 Status changed from not yet recruiting to recruiting.